This acquisition won’t make VNL any bigger than its current MC. On a ebitda multiple basis, vnl is paying 24x current ebitda or 4x future potential ebitda. This is very buoyant.
Current market is paying 7-8x ebitda for pharmacies and 4-6x ebitda for gp clinics as a comparison.
This acquisition won’t make VNL any bigger than its current MC....
Add VNL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.015(10.7%) |
Mkt cap ! $130.0M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 16.0¢ | 13.0¢ | $221.1K | 1.491M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2826 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 835169 | 5 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
15.0¢ |
Change
0.015 ( 15.4 %) |
||||
| Open | High | Low | Volume | ||
| 15.0¢ | 15.5¢ | 15.0¢ | 34206 | ||
| Last updated 14.59pm 03/05/2024 ? | |||||
| VNL (ASX) Chart |